The Rundown — October 9, 2026

THE WORLD · OCTOBER 9, 2026

What's going on right now, in one place. The ↗ links out to the original source; the item's own text turns into a link only once it becomes a full entry here.

The world

• Ukrainian President Volodymyr Zelensky said October 1 that Ukraine used its domestically built FP-7 ballistic missile — made by the Ukrainian firm Fire Point, with a reported range near 200–250 km and a roughly 150 kg warhead — in combat for the first time, without disclosing the target or location. ↗
• OPEC+'s seven core members agreed October 4 to hold November crude output at September's levels, about 31.01 million barrels a day combined, continuing a pause after four straight months of production hikes as Strait of Hormuz disruptions keep actual exports below target. ↗

Bitcoin & crypto

• Bitcoin fell below $81,000 on October 8 as Middle East-driven market stress pushed crypto liquidations past $1.1 billion in 24 hours per CoinGlass, before partially recovering to around $82,500 by Friday morning. ↗

Science

• The 2026 Nobel Prize in Chemistry went jointly to Henri B. Kagan of Université Paris-Sud and Kenso Soai, 95, of Tokyo University of Science, announced October 7 "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis." ↗

Space

• NASA's Crew-13 launched October 1 aboard SpaceX's Dragon capsule Grace, carrying commander Jessica Watkins, pilot Luke Delaney, and mission specialists Joshua Kutryk (Canada) and Sergey Teteryatnikov (Russia) for a roughly six-month ISS stay; Watkins becomes the first NASA astronaut to fly twice on a Dragon. ↗

Arts & culture

• "Verity" opened atop the domestic box office last weekend with $32.6 million across 3,510 theaters, per The Numbers, with the Resident Evil reboot second at $12.5 million. ↗

Health & medicine

• The FDA's priority-review decision on Merck and Daiichi Sankyo's ifinatamab deruxtecan, an antibody-drug conjugate for previously treated extensive-stage small-cell lung cancer backed by the Phase 2 IDeate-Lung01 trial, is due October 10. ↗